Skip to main content
MEDIPOSTCO.,LTD. logo

MEDIPOSTCO.,LTD. — Investor Relations & Filings

Ticker · 078160 ISIN · KR7078160009 KO Manufacturing
Open in API
Filings indexed 366 across all filing types
Latest filing 2023-10-27 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 078160

About MEDIPOSTCO.,LTD.

https://en.medi-post.co.kr/

MEDIPOST is a biotechnology company specializing in the research, development, and commercialization of stem cell therapeutics and regenerative medicine. The company focuses on addressing unmet medical needs for incurable diseases through its proprietary stem cell platform technology. Its core operations include a cord blood banking service and the development of allogeneic stem cell therapies. Key commercialized products include CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. The company's clinical pipeline features next-generation injectable treatments for conditions such as osteoarthritis and diabetic nephropathy.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Capital Increase Decision' (유상증자결정) for MediPost Co., Ltd. It details the correction of a previously filed report, specifically updating the final issuance price and the purpose of the funds. This type of filing, which details changes to capital structure, share issuance, and pricing, falls under the 'Share Issue/Capital Change' category.
2023-10-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report changes in share ownership by major shareholders or insiders, which corresponds to the 'Director's Dealing' (DIRS) category in the provided schema.
2023-10-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by insiders or major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS) as it reports personal share transactions by major shareholders/insiders.
2023-10-27 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission (금융위원회) in South Korea. It specifically details the finalization of issuance terms for a capital increase (유상증자) by Medi-Post Co., Ltd. The document provides detailed tables comparing 'before' and 'after' figures for the offering price and total amount, which is characteristic of a formal regulatory filing for capital changes. Since this is a formal regulatory document regarding share issuance and capital structure, it falls under the 'Share Issue/Capital Change' category.
2023-10-27 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Correction Report' (정정신고) for a 'Prospectus' (투자설명서) regarding a capital increase (유상증자) by Medipost Co., Ltd. It details the finalization of the issuance price (확정 발행가액) and updates the associated financial data and shareholding simulations. In the context of financial filings, a prospectus amendment related to capital raising is classified under 'Share Issue/Capital Change'.
2023-10-27 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) from Medi-Post, detailing quarterly revenue and operating profit figures. It provides key financial highlights for the 3rd quarter of 2023 compared to previous periods. As it is an initial announcement of financial results rather than a full comprehensive report, it falls under the Earnings Release category. Q3 2023
2023-10-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.